Dr. Vivek K. Narayan, MD

Dr. Narayan practices at Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania.

Dr. Narayan's NPI, 1346568011, was assigned on May 5, 2010. Dr. Narayan graduated from University of Virginia School of Medicine in 2010. Dr. Narayan holds Pennsylvania license MD447525.

Dr. Narayan's primary practice is Hospital of the University of Pennsylvania, at 3400 Spruce St, Philadelphia, PA 19104 in Philadelphia County. The practice phone is (215) 662-6289.

Dr. Narayan's primary practice is Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania. Dr. Narayan is also affiliated with Penn Presbyterian Medical Center. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Narayan to 2 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Narayan practices, 6 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Narayan's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Narayan is licensed in Pennsylvania.

CMS data shows 968 Medicare services from Dr. Narayan across 5 procedure codes in 2024, for 249 Medicare patients. Medicare paid $52,836 for them.

CMS counts 249 Medicare patients who saw Dr. Narayan in 2024. The largest group is 65 to 74, with 128 patients. 75% of them have cancer, and 75% have high blood pressure. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Narayan's median patient age at 72, with 10% women.

In 2024, Dr. Narayan wrote 456 Medicare Part D claims for 110 patients. 44% of them were for generic drugs. CMS names the drug for 389 of them, across 12 drugs with 11 or more claims each, at $4,185,086 in total drug cost. In 2023, CMS named 390 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Narayan for performance year 2024, reported as part of a group. Dr. Narayan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Narayan as offering telehealth.

Dmand AI links 93 papers to Dr. Narayan, published from 2011 to 2025. 2019 was the busiest year, with 10. The most frequent topics are Prostatic Neoplasms, Antineoplastic Agents and Antineoplastic Combined Chemotherapy Protocols. Dr. Narayan has published most often in Clin Genitourin Cancer. Dr. Narayan's most frequent co-authors are Bonnie Ky, MD, Amy S. Clark, MD and Ravi Bharat Parikh, MD.

Dmand AI links Dr. Narayan to 9 clinical trials, 3 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Carcinoma, Renal Cell, Kidney Neoplasms and Prostatic Neoplasms. Abramson Cancer Center at Penn Medicine sponsors the most, 2. Open Payments lists research payments to Dr. Narayan that name 1 trial.

CMS Open Payments shows 156 general payments to Dr. Narayan from 23 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 73% of the total. Exelixis Inc. paid the most, $14,915. It also lists 6 research payments totaling $1,201 from 2018 to 2025, naming 1 clinical trial.

Dr. Narayan graduated from University of Virginia School of Medicine in 2010.